WO2020022976A3 - A formulation comprising dexketoprofen - Google Patents

A formulation comprising dexketoprofen Download PDF

Info

Publication number
WO2020022976A3
WO2020022976A3 PCT/TR2018/000136 TR2018000136W WO2020022976A3 WO 2020022976 A3 WO2020022976 A3 WO 2020022976A3 TR 2018000136 W TR2018000136 W TR 2018000136W WO 2020022976 A3 WO2020022976 A3 WO 2020022976A3
Authority
WO
WIPO (PCT)
Prior art keywords
dexketoprofen
formulation
dexketeprofen
pains
pharmaceutically acceptable
Prior art date
Application number
PCT/TR2018/000136
Other languages
French (fr)
Other versions
WO2020022976A2 (en
Inventor
Mahmut Bi̇lgi̇ç
Original Assignee
NEUTEC AR-GE SANAYİ VE TĺCARET ANONİM ŞİRKETİ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEUTEC AR-GE SANAYİ VE TĺCARET ANONİM ŞİRKETİ filed Critical NEUTEC AR-GE SANAYİ VE TĺCARET ANONİM ŞİRKETİ
Publication of WO2020022976A2 publication Critical patent/WO2020022976A2/en
Publication of WO2020022976A3 publication Critical patent/WO2020022976A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

This Invention is related to a pharmaceutical composition in tablet form which provides continuous release comprising a dexketeprofen free base and pharmaceutically acceptable salt thereof as an active agent used In prolonged pain treatment, particularly musculoskeletal system pains.
PCT/TR2018/000136 2017-12-29 2018-12-28 A formulation comprising dexketoprofen WO2020022976A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
TR2017/23035A TR201723035A2 (en) 2017-12-29 2017-12-29 Dexketoprofen delayed release composition.
TR2017/23035 2017-12-29
TR2018/15617A TR201815617A2 (en) 2017-12-29 2018-10-19 A formulation containing dexketoprofen.
TR2018/15617 2018-10-19

Publications (2)

Publication Number Publication Date
WO2020022976A2 WO2020022976A2 (en) 2020-01-30
WO2020022976A3 true WO2020022976A3 (en) 2020-03-12

Family

ID=67900930

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/TR2018/000136 WO2020022976A2 (en) 2017-12-29 2018-12-28 A formulation comprising dexketoprofen
PCT/TR2018/000129 WO2019212426A2 (en) 2017-12-29 2018-12-28 Delayed release dexketoprofen composition

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/TR2018/000129 WO2019212426A2 (en) 2017-12-29 2018-12-28 Delayed release dexketoprofen composition

Country Status (2)

Country Link
TR (2) TR201723035A2 (en)
WO (2) WO2020022976A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115607509B (en) * 2022-10-11 2024-01-30 南京正科医药股份有限公司 Dexketoprofen tromethamine injection and preparation process thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101623280A (en) * 2008-07-10 2010-01-13 广东肇庆星湖生物科技股份有限公司 Compound sustained release preparation for easing pain and preparation method thereof
CN102813638A (en) * 2011-06-07 2012-12-12 贵阳医学院 Preparation method of dexketoprofen trometamol double-layer sustained-release tablets
ES2394888A1 (en) * 2011-06-15 2013-02-06 Farmalider, S.A. Pharmaceutical form of modified release of dexketoprophene and inhibitor of the proton pump and use of the same. (Machine-translation by Google Translate, not legally binding)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201104864A2 (en) * 2011-05-18 2012-12-21 Bi̇lgi̇ç Mahmut Water-soluble formulations containing dexketoprofen.
WO2013022410A2 (en) * 2011-08-08 2013-02-14 Mahmut Bilgic Production method for effervescent formulations comprising dexketoprofen
WO2013095315A1 (en) * 2011-12-19 2013-06-27 Mahmut Bilgic Formulations comprising dexketoprofen (particle size 300-2500 micrometer)

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101623280A (en) * 2008-07-10 2010-01-13 广东肇庆星湖生物科技股份有限公司 Compound sustained release preparation for easing pain and preparation method thereof
CN102813638A (en) * 2011-06-07 2012-12-12 贵阳医学院 Preparation method of dexketoprofen trometamol double-layer sustained-release tablets
ES2394888A1 (en) * 2011-06-15 2013-02-06 Farmalider, S.A. Pharmaceutical form of modified release of dexketoprophene and inhibitor of the proton pump and use of the same. (Machine-translation by Google Translate, not legally binding)

Also Published As

Publication number Publication date
TR201815617A2 (en) 2019-07-22
TR201723035A2 (en) 2019-07-22
WO2019212426A2 (en) 2019-11-07
WO2019212426A3 (en) 2019-11-28
WO2020022976A2 (en) 2020-01-30

Similar Documents

Publication Publication Date Title
MX2016010179A (en) Donepezil compositions and method of treating alzheimer's disease.
JP2015523407A5 (en)
WO2018165404A8 (en) Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol
MX2021013139A (en) Pharmaceutical composition for prevention and/or treatment of atopic dermatitis containing il-31 antagonist as active ingredient.
NZ605469A (en) Nalbuphine-based formulations and uses thereof
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
EA036036B1 (en) Compositions comprising cyclosporin
PH12019500154A1 (en) Formulation having improved ph-dependent drug-release characteristics, containing esomeprazole or pharmaceutically acceptable salt thereof
MX2016016400A (en) Stabilized oxymetazoline formulations and their uses.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MX2017005163A (en) Onapristone extended-release compositions and methods.
WO2020022976A3 (en) A formulation comprising dexketoprofen
GR1008228B (en) Pharmaceutical composition comprising a dual reuptake inhibitor and method for the preparation thereof
ZA201905309B (en) Pharmaceutical active ingredient and use thereof, in particular for the prevention and treatment of metabolic disorders in humans and animals
SA516370446B1 (en) Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
MX2020003697A (en) Pharmaceutical formulations comprising opioid receptor agonist as active ingredients, methods of manufacture and therapeutic uses thereof.
WO2015166418A3 (en) Pharmaceutical composition for the treatment of allopathic pain, using ketorolac tromethamine and tramadol hydrochloride as an active ingredient
PH12016500120A1 (en) Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
MX2020006886A (en) Drug delivery system.
MX2019005005A (en) Extended release tablet comprising a weight-loss drug.
PH12020550597A1 (en) Formulation having improved hygroscopic property and dissolution rate comprising telmisartan or its pharmaceutically acceptable salt
WO2018084817A3 (en) A new form of active agent
UA91282U (en) Drug formulation possessing pronounced antigestagenic activity
IN2013MU02110A (en)
GB2541348A (en) Clopidogrel for use in the treatment of benign prostatic hyperplasia

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18927387

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18927387

Country of ref document: EP

Kind code of ref document: A2